Clinical Trial: Sequential Zoledronic Acid at 3 Months Versus 6 Months After Discontinuation of Long-term Denosumab Therapy in Patients with Primary Osteoporosis: A Prospective, Open-label, Randomized Controlled Trial (China)

China, Aug. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Sequential Zoledronic Acid at 3 Months Versus 6 Months After Discontinuation of Long-term Denosumab Therapy in Patients with Primary Osteoporosis: A Prospective, Open-label, Randomized Controlled Trial'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130359

Registration Time: 2026/08/19

Type: Interventional study

Primary Sponsor: Tongji Hospital of Tongji University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=332413

Published by HT Digital Content Services with permission from Health Daily Digest....